510(k) device
Sensus
Neurometrix, Inc. · Stimulator, Nerve, Transcutaneous, For Pain Relief (GZJ, Class II) · First FDA decision Aug 2, 2012, newest Jul 2, 2013Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
3
Naming "Sensus"
MAUDE reports
9
Brand "Sensus", since 2015
PubMed studies
65
Mentioning "Sensus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Sensus
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- SENSUS510(k)
K130919 · Decided Jul 2, 2013 · 90 days after receipt
Device type: Stimulator, Nerve, Transcutaneous, For Pain Relief (GZJ) · Neurology & Neurosurgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
- Transcutaneous Electrical Nerve Stimulation for Chronic Low Back PainNational analysisReview closedCAG-00429NUpdated Sep 24, 2026
- Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Low Back Pain (CLBP)National determinationOn the books160.27Updated Feb 10, 2026
- Transcutaneous Electrical Nerve Stimulation (TENS) for Acute Post-Operative PainNational determinationOn the books10.2Updated Dec 2, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Supplies Used in the Delivery of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES)National determinationOn the books160.13Updated Aug 16, 2023
- Phrenic Nerve StimulatorNational determinationOn the books160.19Updated Jun 12, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Sensus", any status and sponsor, newest update first.
- Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term MedicationNot yet recruiting
San Diego State UniversityAcademic, hospital or other
NCT06865755 · 15 participants (planned) · Start Dec 2026 · Primary completion Dec 2026
Device: integrated medication monitoring (MM) system · For: Breast Cancer Survivor; Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Sites: San Diego, California
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Sensus", and for the whole product code for context.
This brand
9 reports: 0 malfunction, 9 injury, 0 death
Whole product code GZJ
239 reports: 42 malfunction, 195 injury, 0 death
Newest reports for this brand
- SENSUS SRT 100Injury
MW5151829 · Received Feb 21, 2024
Device type: System, Therapeutic, X-Ray (JAD)
Device problem as coded: Material Integrity Problem
Patient problem as coded: Pain
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Sensus"[tiab]. The summary above synthesizes these.
- Pegvisomant. Pharmacia.
Goffin V, Touraine P · Curr Opin Investig Drugs · 2002Review
- [Sensus orthopedicus].
Hackenbroch M · Z Orthop Ihre Grenzgeb · 1972
- A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study.
Marozzi MS, Cicco S, Mancini F, et al. · Diagnostics (Basel) · 2024
- SensUs: Challenging the Next Generation of Sensor Scientists.
Merkx M · ACS Sens · 2017
- Pegvisomant Pfizer/Sensus.
Goffin V, Touraine P · Curr Opin Investig Drugs · 2004Review
- Focus, locus, and sensus: the three dimensions of virtual experience.
Waterworth EL, Waterworth JA · Cyberpsychol Behav · 2001
- Monte Carlo modeling of radiation dose from radiation therapy with superficial x-rays.
Barghash R, Martin TW, Prebble AR, et al. · J Appl Clin Med Phys · 2025
- Differential interactions of Rickettsia species with tick microbiota in Rh. sanguineus and Rh. turanicus.
Maitre A, Kratou M, Corona-Guerrero I, et al. · Sci Rep · 2024
- A Retrospective Registry Study Evaluating the Long-Term Efficacy and Safety of Superficial Radiation Therapy Following Excision of Keloid Scars.
Berman B, Nestor MS, Gold MH, et al. · J Clin Aesthet Dermatol · 2020Review
- Hexanoic acid production and microbial community in anaerobic fermentation: Effects of inorganic carbon addition.
Ji X, Chen Z, Shen Y, et al. · Bioresour Technol · 2024
- Characterization of virulence properties in the C. parapsilosis sensu lato species.
Németh T, Tóth A, Szenzenstein J, et al. · PLoS One · 2013Research Support, Non-U.S. Gov't
- Problem exploration for creating value propositions when developing point-of-care solutions.
Bobelyn A, Unteregger R, Höffken JI, et al. · Biosens Bioelectron · 2023
Other devices of this type
Also filed under product code GZJ.
- Electro-Nerve Stimulator Tens, Model BMLS06-1Biomedical Life Systems, Inc. · 510(k) 2006
- Transcutaneous Electrical Nerve Stimulator (model: TENS WMPS6-1)Wuxi Jiajian Medical Instrument Co., Ltd. · 510(k) 2023
- ReliefBandReliefband Technologies, LLC · 510(k) 2019
- Quadra Bloc TENS PlusGradient Technologies, LLC · 510(k) 2011
- Combocare 2000Xanacare Technologies, LLC · 510(k) 2008
- STIMPOD NMS460 Nerve StimulatorAlgiamed Technologies USA, Inc. · 510(k) 2026
- actiTENS miniSublimed · 510(k) 2026
- CP Relief Wand Rx - TENS/NMESN & C Holdings, LLC · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.